The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight …

B Make, NA Hanania, R ZuWallack, C Kalberg… - Clinical …, 2005 - Elsevier
BACKGROUND:: The pathology of chronic obstructive pulmonary disease (COPD) includes
both obstructive and inflammatory components. OBJECTIVE:: The aim of this study was to …
被引用次数：29 相关文章

The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight …

B Make, NA Hanania, R ZuWallack… - Clinical …, 2005 - pubmed.ncbi.nlm.nih.gov
Background The pathology of chronic obstructive pulmonary disease (COPD) includes both
obstructive and inflammatory components. Objective The aim of this study was to confirm the …

The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: An eight …

B Make, NA Hanania, R ZuWallack, C Kalberg… - Clinical …, 2005 - infona.pl
AbstractThe pathology of chronic obstructive pulmonary disease (COPD) includes both
obstructive and inflammatory components. The aim of this study was to confirm the findings …

[引用][C] The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: An …

B MAKE, NA HANANIA, R ZUWALLACK… - Clinical …, 2005 - pascal-francis.inist.fr
The efficacy and safety of inhaled fluticasone propionate/ salmeterol and ipratropium/albuterol
for the treatment of chronic obstructive pulmonary disease : An eight-week, multicenter …

The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight …

B Make, NA Hanania, R ZuWallack, C Kalberg… - Clinical …, 2005 - europepmc.org
Objective The aim of this study was to confirm the findings of a previous study that compared
the efficacy of a combination of 2 short-acting bronchodilators with the use of an inhaled …

The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: An eight …

B Make, NA Hanania, R ZuWallack… - Clinical …, 2005 - clinicaltherapeutics.com
Background: The pathology of chronic obstructive pulmonary disease (COPD) includes both
obstructive and inflammatory components. Objective: The aim of this study was to confirm …

[引用][C] The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: An …

B MAKE, NA HANANIA, R ZUWALLACK… - Clinical …, 2005 - Elsevier

[引用][C] The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: An …

B Make, NA Hanania, R ZuWallack, C Kalberg… - Clinical …, 2005 - Elsevier Limited